Learn in an intimate setting. Walk away with valuable clinical skills.
The 2020 SNMMI Mid-Winter and ACNM Annual Meeting's intimate format provides an ideal setting to actively collaborate with luminaries in the field, further develop relevant skills, and deliver techniques you can implement immediately when you return to work. This year's meeting will feature three educational tracks open to all attendees, including a dedicated track on Neuroimaging.
The SNMMI 2020 Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The four day event, taking place each June, provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as providing insights into practical applications for the clinic.
Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.
Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.
SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.
The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:
SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.
The December issue of the Journal of Nuclear Medicine Technology is now available, including 3 CE articles, 10 scientific articles, 2 teaching case studies and a Practical Pointer. Check it out.
A novel nuclear medicine radiotracer could help identify the extent of metastatic prostate cancer and select patients for therapy. The study is featured in The Journal of Nuclear Medicine.
After reviewing the NCDs for PET for Myocardial Perfusion and PET for Myocardial Viability, CMS clarified that PET quantitative myocardial blood flow is coverable under these NCDs.
(Government Relations News)
Researchers have discovered a new way to optimize results in treating patients with prostate cancer tumors while minimizing negative side effects. The study is featured in the November issue of The Journal of Nuclear Medicine.
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
Learn more about journals published by or sponsored by the Society of Nuclear Medicine and Molecular Imaging.